These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 16527424

  • 1. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus.
    Takahashi KA, Castillo PE.
    Neuroscience; 2006; 139(3):795-802. PubMed ID: 16527424
    [Abstract] [Full Text] [Related]

  • 2. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
    Hoffman AF, Macgill AM, Smith D, Oz M, Lupica CR.
    Eur J Neurosci; 2005 Nov; 22(9):2387-91. PubMed ID: 16262678
    [Abstract] [Full Text] [Related]

  • 3. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N, Ledent C, Freund TF.
    Neuroscience; 2001 Nov; 106(1):1-4. PubMed ID: 11564411
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.
    Hájos N, Freund TF.
    Neuropharmacology; 2002 Sep; 43(4):503-10. PubMed ID: 12367597
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D, Almado CE, Dagostin AL, Machado BH, Leão RM.
    Brain Res; 2008 Mar 20; 1200():1-9. PubMed ID: 18308297
    [Abstract] [Full Text] [Related]

  • 7. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission.
    Haller J, Mátyás F, Soproni K, Varga B, Barsy B, Németh B, Mikics E, Freund TF, Hájos N.
    Eur J Neurosci; 2007 Apr 20; 25(8):2445-56. PubMed ID: 17445240
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
    Hoffman AF, Laaris N, Kawamura M, Masino SA, Lupica CR.
    J Neurosci; 2010 Jan 13; 30(2):545-55. PubMed ID: 20071517
    [Abstract] [Full Text] [Related]

  • 10. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL.
    J Neurosci; 2004 Jan 07; 24(1):53-62. PubMed ID: 14715937
    [Abstract] [Full Text] [Related]

  • 11. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
    Bajo M, Roberto M, Schweitzer P.
    J Neurosci Res; 2009 Feb 15; 87(3):766-75. PubMed ID: 18816788
    [Abstract] [Full Text] [Related]

  • 12. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC, Lo SW, Hsu KS.
    J Physiol; 2001 May 01; 532(Pt 3):731-48. PubMed ID: 11313442
    [Abstract] [Full Text] [Related]

  • 13. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Sep 01; 56(3):185-92. PubMed ID: 17656103
    [Abstract] [Full Text] [Related]

  • 14. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G, Lovinger DM.
    J Neurophysiol; 2001 Jan 01; 85(1):468-71. PubMed ID: 11152748
    [Abstract] [Full Text] [Related]

  • 15. Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity.
    Reich CG, Mihalik GR, Iskander AN, Seckler JC, Weiss MS.
    Neuroscience; 2013 Dec 03; 253():444-54. PubMed ID: 24035826
    [Abstract] [Full Text] [Related]

  • 16. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
    Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, Kano M.
    Eur J Neurosci; 2004 May 03; 19(10):2682-92. PubMed ID: 15147302
    [Abstract] [Full Text] [Related]

  • 17. Excitatory afferents to CA3 pyramidal cells display differential sensitivity to CB1 dependent inhibition of synaptic transmission.
    Hofmann ME, Nahir B, Frazier CJ.
    Neuropharmacology; 2008 Dec 03; 55(7):1140-6. PubMed ID: 18675282
    [Abstract] [Full Text] [Related]

  • 18. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.
    Mátyás F, Yanovsky Y, Mackie K, Kelsch W, Misgeld U, Freund TF.
    Neuroscience; 2006 Dec 03; 137(1):337-61. PubMed ID: 16289348
    [Abstract] [Full Text] [Related]

  • 19. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
    Kim J, Li Y.
    J Physiol; 2015 Feb 15; 593(4):871-86. PubMed ID: 25504573
    [Abstract] [Full Text] [Related]

  • 20. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.
    Takahashi KA, Linden DJ.
    J Neurophysiol; 2000 Mar 15; 83(3):1167-80. PubMed ID: 10712447
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.